Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 835 results for "iias"

Former Bengal governor Gopalkrishna Gandhi calls CBI department of dirty tricks, RIL a parallel state
Times of India

CBI is govt's dirty tricks dept, says former Bengal Governor G...

Chairman Governing Body, IIAS, Gopalkrishna Gandhi and CBI Director Ranjit Sinha in New Delhi on Tuesday. Prem Nath pandey Summary The Tamil Nadu cadre IAS officer said the CBI will play a big role in future of India's public. Calling the ... Indian Express, 1 day ago

141 images for iias

CNN, 3 hours ago
Financial Express, 8 hours ago
Institute of Internal Auditors, 21 hours ago
Institute of Internal Auditors, 21 hours ago
Institute of Internal Auditors, 21 hours ago
Seeking Alpha, 3 days ago
Seeking Alpha, 3 days ago
Seeking Alpha, 3 days ago
Seeking Alpha, 3 days ago
Seeking Alpha, 3 days ago

Sun Pharma-Ranbaxy deal: Proxy advisory firm questions Ranbaxy share trading surge

Volumes tripled in 3 days before deal and stock was up 24%, notes IiAS
 Business Standard1 week ago Sebi probing stock bounce before deal  The Financial Chronicle1 week ago New Sebi norms a step ahead of Companies Act  Rediff.com2 months ago
Money Control

Will still advise voting against Gujarat deal: IIAS

Although taking minority shareholders' approval is a welcome step, Amit Tandon, Founder Managing Director of IIAS believes a lot of questions still remain unanswered even after clarification from Maruti Suzuki management.
 Money Control4 weeks ago Guj plant row: institutional investors forum hails Maruti move  Business Standard1 month ago IiAS welcomes Maruti board decision on Gujarat plant  Business Line1 month ago Investor forum hails Maruti Suzuki move  Deccan Herald1 month ago
Money Control

Suzlon needs leadership from outside promoter family: IiAS

IiAS asked the companys shareholders to vote against the re-appointment of the chairman Tulsi Tanti as the managing director after he sought a 50 percent pay hike despite the company going through debt restructuring.
 Money Control3 weeks ago Suzlon shareholders should vote against Tanti: IiAS  India Infoline3 weeks ago Vote against Tanti: advisory firm tells Suzlon shareholders  Business Standard India3 weeks ago

Women's Day observed at IIAS

PANAJI: The IIAS School of Management, Alto-Porvorim in association with the Mixologist, the bartending academy celebrated Women's Day at the School premises. The art of mixing mocktails was taught to enthusiastic women guests, women faculty ...
 Navhind Times4 weeks ago

The Last Minute

In this report The Last Minute - IiAS examines the linkages between the date of the Annual General Meeting (AGM) and company performance.
 Money Control1 month ago

How to fix the president's ballistic missile defense policy

In the wake of the Crimean crisis, a growing chorus of Republican lawmakers and conservative thinkers have called for a reassessment of the president's European missile defense policy. Charles Krauthammer, Dick Cheney, and Sen. Ted Cruz (R-Texas) ...
 The Hill29 minutes ago

ADOCIA Announces First-Quarter 2014 Results

ADOCIAAnnounces First-Quarter 2014 Results EUR 16M cash position EUR 0.1M revenues compared to EUR 0.5M in 2013 Major clinical results obtained for two innovative insulin formulations Regulatory News: Adocia (Paris:ADOC) (Euronext Paris: ...
 Reuters1 hour ago Adocia announces financial results for 2013  Reuters3 weeks ago ADOCIA : annual results 2013  4 Traders3 weeks ago ADOCIA : announces financial results for 2013  4 Traders3 weeks ago

Statutory guidance: Approval of stability information (MSIS 9)

The main requirements are as follows: merchant shipping (load line) regulations 1998, reg 32(5)* for cargo ships; merchant shipping (passenger ship construction: construction of ships of classes I, II and II(A)) regulations 1998, reg 38; and ... hour ago

GlaxoSmithKline and Galapagos succeed in psoriasis after two setbacks

Galapagos and partner GlaxoSmithKline ($GSK) say their anti-inflammation candidate hit its mark in a mid-stage trial on psoriasis, a stroke of good news for a drug beset by developmental slipups. The treatment, GSK2586184, met its primary endpoint ...
 FierceBiotech2 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - iias
Get updated on latest news & your favorite topics right in your inbox!
More     Less